The Impact of Structured Diabetes Education on Glycemic Control in Patients with Type 2 Diabetes at Initiation of Basal Insulin – The Basal-EDUC-RO Study: A Randomized Prospective Study

The Impact of Structured Diabetes Education on Glycemic Control in Patients with Type 2 Diabetes at Initiation of Basal Insulin – The Basal-EDUC-RO Study: A Randomized Prospective Study

Background: Basal-EDUC-RO Study evaluated the impact of structured education provided at the initiation of basal insulin therapy on glycaemic control in patients with uncontrolled type 2 diabetes mellitus (T2D).

Bibliographic Details
Main Authors:	Bala Cornelia, Rusu Adriana, Moise Mihaela, Roman Gabriela
Format:	Article
Language:	English
Published:	Sciendo 2019-06-01
Series:	Romanian Journal of Diabetes Nutrition and Metabolic Diseases
Subjects:	type 2 diabetes basal insulin analogue diabetes self-management education
Online Access:	https://doi.org/10.2478/rjdnmd-2019-0020

Similar Items

Degludec insulin: A novel basal insulin
by: Sanjay Kalra, et al.
Published: (2011-01-01)

The Effect of Basal Analog Insulin on the Glycemic Variability in Type 2 Diabetics
by: Soner Cander, et al.
Published: (2014-06-01)

Modern basal insulins: an ongoing story or the start of a new era?
by: Ivan Ivanovich Dedov
Published: (2015-11-01)

Future of newer basal insulin
by: S V Madhu, et al.
Published: (2013-01-01)

Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
by: Han Na Jang, et al.
Published: (2019-12-01)

Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus
by: Puhong Zhang, et al.
Published: (2020-04-01)

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
by: Eun Yeong Choe, et al.
Published: (2012-06-01)

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China
by: Guangxu Liu, et al.
Published: (2018-10-01)

Glycemic control with a basal-bolus insulin protocol in hospitalized diabetic patients treated with glucocorticoids: a retrospective cohort study
by: Elena Chertok Shacham, et al.
Published: (2018-10-01)

Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes
by: Jesús Berián, et al.
Published: (2021-08-01)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
by: Trevor J. Orchard, et al.
Published: (2017-06-01)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
by: Natalya Nikitichna Volevodz, et al.
Published: (2013-03-01)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
by: Dippel, Franz-Werner, et al.
Published: (2010-01-01)

Predictors of Glycemic Response and Change in HbA1c Following Newly Initiated Basal Insulin Among Insulin Naïve Adults With Type 2 Diabetes
by: Mojtaba Malek, et al.
Published: (2017-10-01)

Effectiveness and safety of flexible therapeutic schemes including first- and secondgeneration basal insulins during a pediatric summer diabetes camp
by: Stefano Tumini, et al.
Published: (2020-04-01)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
by: Marina Vladimirovna Shestakova, et al.
Published: (2015-11-01)

Basal Insulin Initiation in Elderly Patients with Type 2 Diabetes in Taiwan: A Comparison with Younger Patients
by: Ming-Nan Chien, et al.
Published: (2015-09-01)

Comparison of the influence of oral antidiabetic drug and combined with basal insulin treatment on diabetic control and micro-inflammatory state in type 2 diabetes mellitus patients
by: Gang Wu, et al.
Published: (2016-06-01)

OPTIMAL REGIMENS OF THE BASAL-BOLUS INSULIN THERAPY IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
by: G. A. Galkina, et al.
Published: (2015-10-01)

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
by: Kalirai S, et al.
Published: (2020-04-01)

Insulin therapy is a personalized approach to glycemic management in diabetes
by: T. Yu. Demidova, et al.
Published: (2020-12-01)

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
by: Rodrigo Oliveira Moreira, et al.
Published: (2018-04-01)

Modern basal insulin analogs: An incomplete story
by: Awadhesh Kumar Singh, et al.
Published: (2014-01-01)

Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents
by: Günay Demir, et al.
Published: (2021-06-01)

A study to assess the unmet medical needs associated with the use of basal insulin in patients with type 2 diabetes
by: Gustavo Frechtel, et al.
Published: (2021-01-01)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
by: Cai X, et al.
Published: (2020-04-01)

Effect of basal insulin combined with acarbose on blood glucose level and complications in patients with newly diagnosed elderly diabetes
by: Yu-Qing Guo, et al.
Published: (2016-05-01)

Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A 1 chieve study
by: Arpandev Bhattacharyya, et al.
Published: (2014-01-01)

The Automatic Regulation of the Basal Dose on the Insulin Pump for the Treatment of Patients that have Diabetes Type 1
by: Sifet Mehanović, et al.
Published: (2010-05-01)

Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?
by: Sanjay Kalra
Published: (2015-01-01)

Lipoproteína (a) está associada com níveis basais de insulina em pacientes com Diabetes Mellitus tipo 2 Lipoproteína (a) está asociada a niveles basales de insulina en pacientes con Diabetes Mellitus tipo 2 Lipoprotein (a) is associated with basal insulin levels in patients with type 2 Diabetes Mellitus
by: Syed Shahid Habib, et al.
Published: (2009-07-01)

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
by: Kress S, et al.
Published: (2021-03-01)

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01)

Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system
by: Psota M, et al.
Published: (2017-12-01)

Insulin degludec
by: Vishakha V Jain, et al.
Published: (2013-01-01)

Reduction of Sulfonylurea with the Initiation of Basal Insulin in Patients with Inadequately Controlled Type 2 Diabetes Mellitus Undergoing Long-Term Sulfonylurea-Based Treatment
by: Yeoree Yang, et al.
Published: (2016-10-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Lack of coordination between partners: investigation of Physician-Preferred and Patient-Preferred (4P) basal insulin titration algorithms in the real world
by: Zhang T, et al.
Published: (2018-07-01)

Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis
by: Denis Raccah, et al.
Published: (2019-07-01)

Insulin therapy of type 2 diabetes mellitus
by: G.F. Gendeleka, et al.
Published: (2020-02-01)